Zusammenfassung
Malignome des Gastrointestinaltrakts stellen zusammengenommen die häufigste krebsbedingte Todesursache in Deutschland dar. Die Morbidität durch diese Erkrankungen ist erheblich. Trotz der Fortschritte in der chirurgischen und medikamentösen Therapie gastrointestinaler Malignome besteht im fortgeschrittenen Stadium in der Regel keine Heilungsmöglichkeit mehr. Präventionsmaßnahmen und Screening können die Letalität durch diese Karzinome senken. Vermeidung von Übergewicht bzw. Gewichtsabnahme sowie Nikotinkarenz sind effektive vorbeugende Maßnahmen bei Ösophagus-, Pankreas- und kolorektalem Karzinom. Behandlung von Infektionen durch Hepatitisviren und Helicobacter pylori schützt vor hepatozellulärem Karzinom bzw. Magenkarzinom. Das beste Beispiel für eine wirksame Vorsorgeuntersuchung ist die Koloskopie. Durch die Koloskopie können kolorektale Adenome und Karzinome frühzeitig entdeckt, Adenome als Präkanzerosen endoskopisch in gleicher Sitzung entfernt werden. Der Einsatz einfacher Präventionsstrategien und effizienter Vorsorgemaßnahmen bei gastrointestinalen Malignomen wird im vorliegenden Beitrag praxisnah erläutert.
Abstract
Malignancies of the gastrointestinal tract are the most common causes of cancer-related deaths in Germany. They also induce significant morbidity. Despite both surgical and medical therapeutic improvements, advanced stages of these cancers can rarely be cured. Preventive and screening measures are suitable to decrease gastrointestinal cancer-related mortality. Weight reduction and cessation of smoking are effective in preventing esophageal, pancreatic and colorectal cancer. Treatment of infections like chronic viral hepatitis and helicobacter pylori gastritis is able to protect from hepatocellular and gastric cancer, respectively. Colonoscopy is one of the best established screening methods. It allows early detection of colorectal neoplasia. Preneoplastic adenomas can be endoscopically removed during the same session. We here review simple prevention strategies and effective screening methods in gastrointestinal cancers of relevance in daily practice.
Literatur
Adler G, Seufferlein T, Bischoff SC et al. (2007) S3-Guidelines „Exocrine pancreatic cancer“ 2007. Z Gastroenterol 45: 487–523
Bareiss D, Stabenow R, Müller R et al. (2002) Current epidemiology of carcinoma of the esophagus and cardia in Germany. Dtsch Med Wochenschr 127: 1367–1374
Brenner H, Arndt V, Stürmer T et al. (2001) Long-lasting reduction of risk of colorectal cancer following screening endoscopy. Br J Cancer 85: 972–976
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweigth, obesity, and mortality from cancer in a prospectively study cohort of U.S. adults. N Engl J Med 348: 1625–1638
Camma C, Giunta M, Andreone P, Craxi A (2001) Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach. J Hepatol 34: 593–602
Chang MH, Chen CJ, Lai MS et al. (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 336: 1855–1859
Corey KE, Schmitz SM, Shaheen NJ (2003) Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett’s esophagus? A meta-analysis. Am J Gastroenterol 98: 2390–2394
Fuchs CS, Colditz GA, Stampfer MJ et al. (1996) A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 156: 2255–2260
Gesundheitsberichterstattung des Bundes http://www.gbe-bund.de
Greten TF, Wedemeyer H, Manns MP (2006) Prävention Virus-assoziierter Karzinomentstehung am Beispiel des hepatozellulären Karzinoms. Dtsch Arztebl 103: A1817–A1822
International Agency for Research on Cancer (2003) Fruits and vegetables. In: International agency for research on cancer (ed) Handbooks of cancer prevention, vol 8. IARC Press, Lyon
Kakizoe T (1999) Cancer statistics in Japan. Foundation for Promotion of Cancer Research, Tokyo
Koop H, Schepp W, Müller-Lissner S et al. (2005) Consensus conference of the DGVS on gastroesophageal reflux. Z Gastroenterol 43: 163–164
Liaw YF, Sung JJ, Chow WC et al. Cirrhosis Asian Lamivudine Multicentre Study Group (2004) Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351: 1521–1531
Lindblad M, Rodriguez LA, Lagergren J (2005) Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control 16: 285–294
Malfertheiner P, Megraud F, O’Morain C et al. (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut 56: 772–781
Michaud DS, Giovannucci E, Willett WC et al. (2001) Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 286: 921–929
Rapp K, Schroeder J, Klenk J et al. (2005) Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer 93: 1062–1067
Schmiegel W, Pox C, Adler G et al. (2004) S3-Guidelines Conference „Colorectal Carcinoma“ 2004. Z Gastroenterol 42: 1129–1177
Sharma P, Reker D, Falk G et al. (2001) Progression of Barrett’s esophagus to highgrade dysplasia and cancer – preliminary results of the Barrett’s esophagus study trial. Gastroenterology 120: A16
Tanaka K, Hirohata T, Takeshita S et al. (1992) Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, Japan. Int J Cancer 51: 509–514
Towler BP, Irwig L, Glasziou P et al. (2000) Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst Rev 2: CD001216; Update 2007: Cochrane Database Syst Rev 1: CD001216
Wang WH, Huang JQ, Zheng GF et al. (2003) Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst 95: 1784–1791
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hoffmeister, A., Schiefke, I., Teich, N. et al. Prävention von Malignomen des Verdauungstrakts. Internist 49, 178–184 (2008). https://doi.org/10.1007/s00108-007-1998-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00108-007-1998-3